Skip to main content
. 2018 Feb 17;19(2):575. doi: 10.3390/ijms19020575

Figure 3.

Figure 3

Proposed scheme of angiotensin (ANG) II-induced inhibition of protein kinase B (AKT) activation by insulin. Vascular agonist ANG II activates protein kinase C (PKC), which inhibits phosphorylation of insulin receptor substrate 1 (IRS1), phosphoinositide 3 kinase (PI3K) activation, and AKT activation.